Sunil Healthcare submits board meeting intimation

Sunil Healthcare has informed that pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, the 266th Meeting of the Board of Directors of the Company, is scheduled to be held on Friday, February 06, 2026 at the Registered office 38E/252A, Vijay Tower, 3rd Floor, Panchsheel Commercial Complex, Shahpur Jat, New Delhi-110049 (deemed venue), through video conferencing/Audio visual connection, to consider, approve and take on record the Un-audited Financial Results (both standalone and consolidated) for the 3rd quarter/nine months ended on December 31, 2025 of the Financial Year 2025-26. The said financial results shall be sent for Limited Review by the Statutory Auditors of the Company. Further, the Trading Window, under the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as already intimated on 29.12.2025 vide letter dated 29.12.2025, shall remain close from January 01, 2026 till February 08, 2026.

The above information is a part of company’s filings submitted to BSE.